Profile
Dr (MD) Hannah Pressler
Charité – Universitätsmedizin Berlin, Germany
Presentation
12:00 CEST / Session: Treatment II: Clinical trials targeting immune dysregulation
Immunoadsorption in ME/CFS and Post-COVID ME/CFS: First Results from the IA-PACS-CFS Randomized Sham-Controlled Trial
Dr Hannah Pressler is a postdoctoral researcher at the Department of Neurology with Experimental Neurology at Charité – Universitätsmedizin Berlin. Her research focuses on autoimmune-mediated neurological diseases. She also leads the IP/CIDP cohort (Immune-mediated polyneuropathy / chronic inflammatory demyelinating polyneuropathy (CIDP) – Diagnostic, prognostic, and therapy-response markers) at the NeuroCure Cluster of Excellence. Dr. Pressler is a member of the study team working on the IA-PACS-CFS trial, a randomised, controlled clinical trial investigating the efficacy of immunoadsorption in ME/CFS patients.
